Peter G. Goldschmidt, MD, DrPH, DMS
Founder & President

Peter G. Goldschmidt

Peter G. Goldschmidt is Founder & President of Health Improvement Institute, a non-profit, tax-exempt 501(c)(3), organization dedicat-ed to improv-ing the quality and productivity of Ameri-ca's health care. The Institute is best known for its awards programs, including the annual Aesculapius Awards honoring excel-lence in health communications through World Wide Web sites and television and radio public service announce-ments. Dr. Goldschmidt is also Founder/President of World Development Group, Inc. He was Founder/CEO of Medical Care Management Corporation, and formally Director of Health Services Research & Development Service, U.S. Department of Veterans Affairs (VA), Washington, DC.

Dr. Goldschmidt has a long-standing interest in the quality of health information and in enabling people to become educated consumers. He has extensive experience conducting health policy studies, and in the design and deployment of health information and decision support/expert systems/technologies. He is an expert on outcomes research and cost-effectiveness analysis, and the author of the comprehensive manual Quality management in heath care (published by McGraw Hill, 1995). For the U.S. Department of Defense, he designed the worldwide Civilian External Peer Review Program. He also designed QSM, the first commercially-available system for routinely assessing the quality of hospital care. As a consultant to the Institute of Medicine, he designed the Medical Technology Assessment Directory. He is a former member of the U.S. Technology Coordinating Committee. His activities for the U.S. Congress Office of Technology Assessment included writing a background paper for its study on the quality of medical care and serving on the advisory panel for its study of VA Decentralized Hospital Computer Systems. His most important studies include the Medical Practice Information Demonstration Project (for the U.S. Department of Health and Human Services), and a Comprehensive Study of the Ethical, Legal, and Social Implications of Biomedical and Behavioral Research and Technology (a study mandated by the U.S. Congress). Dr. Goldschmidt's international health experience includes missions for the U.S. Trade and Development Agency (US-TDA), U.S. Agency for International Development (US-AID), World Bank, and World Health Organization (WHO).

Dr. Goldschmidt is a graduate of University College Hospital Medical School (London), the University of Westminster School of Management Studies (London), and the Johns Hopkins University Bloomberg School of Public Health.